Tejaswi Kompala

Clinical Strategy @Teladoc | Endocrinologist via @UCSF | Interests in diabetes, obesity | population health & prevention | behavior change | tweets my own

[Michael Albert, MD @MichaelAlbertMD]

🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟

https://t.co/FksorF3aqe

[Tejaswi Kompala @tkompala]

@chrissyfarr Teladoc Health CISO Sara Hall!

[Tejaswi Kompala @tkompala]

Sigh. I'm all for improving our food environment, but we can't go back on all the progress that has been made...

[Craig Spencer MD MPH @Craig_A_Spencer]

RFK Jr’s nomination is the repudiation of a century of unprecedented and miraculous progress in public health.

We take it for granted because we don’t recognize how far we’ve come.

I recently wrote in @TheAtlantic about what we risk losing. Gift link 👇

https://t.co/rVXqEzE2qT

[Tejaswi Kompala @tkompala]

Bright spot for me on today's #WorldDiabetesDay2024 was discussing diabetes and wellbeing w colleagues at @TeladocHealth

[Tejaswi Kompala @tkompala]

Interesting modeling study abt deaths averted with hypothetical increase in GLP1/GIP coverage + uptake - with the key point being:

It's not just about weight loss. There's real cardiometabolic health risk that can be improved w incretin therapy.

https://t.co/XNSeM1mOHH

[Andrea C. Love, PhD @dr_andrealove]

If MAHA cares about “making Americans healthy” I expect to see:

Expansion of Medicare & Medicaid
Vaccine requirements for schools
Affordable healthcare for ALL
Implementing modern agriculture tools for food crops
Addressing lies about conventionally-grown foods

1/

[Christina Farr @chrissyfarr]

Just asked @ZekeEmanuel about what we should be doing next for America’s health to have the greatest impact. His answer made me jump out of my chair.

Invest in our children. The earlier, the better. Their nutrition, their education, the right early inventions. We can afford it *and* it pays for itself.

More to come on the Second Opinion pod!

[Tejaswi Kompala @tkompala]

@BevTchangMD describing a future of obesity care + healthcare - where we use pharmacotherapy towards all 3 goals

also w a healthy dose of humor 😂#OW2024 @ObesityWeek

[Tejaswi Kompala @tkompala]

standing room only at @RamiBailony re real world long term AOM (1st and 2nd gen) vs intensive behav. Interesting findings: short term AOM use <48 weeks not impactful.
‘focus on the relationships’ - AOMs a tool to help people successfully make behav changes
#OW2024 @ObesityWeek

[Michelle Obama @MichelleObama]

Today is the last day for us to #DoSomething to get @KamalaHarris elected! What a remarkable few months this has been — in record time, she’s built an extraordinary campaign, set forth a clear policy agenda, and proven again and again that she will be working not for herself, but for you. She’s done it all with intelligence, integrity, and grace. She has gone above and beyond. She’s more than done her part.

[Tejaswi Kompala @tkompala]

@J_SimonettiMD s fantastic talk on monogenic and syndromic obesity reminds us that

Not all hunger is created equal!

hypothalamic (brain) control can be impacted w pathologic insatiable hunger
#OW2024 @ObesityWeek

[Tejaswi Kompala @tkompala]

@J_SimonettiMD’s fantastic presentation on monogenic and syndromic obesity reminds us…not all hunger is created equally! Hypothalamic (brain) control of hunger can be impacted w a PHYSIOLOGIC insatiable hunger. #OW2024 @ObesityWeek

[Tejaswi Kompala @tkompala]

love Dr Kaplans characterization of obesity care currently as treatment focused — rather than patient focused — arguing that we need to cont working towards comprehensive obesity treatment @ObesityWeek #OW2024

[Tejaswi Kompala @tkompala]

Headed to @ObesityWeek next week? Get your ballots in now! #OW2024

[Karl Nadolsky @DrKarlNadolsky]

#WeightLoss (14% vs 3% placebo + diet/exercise) with #Wegovy improved knee arthritis, STEP-9 published!

@nejm article

https://t.co/RRmcFTpiYk

[Tejaswi Kompala @tkompala]

5 additional areas to add to what we know from pharma trials for real world QOL impact:

[Tejaswi Kompala @tkompala]

We all talk about weight loss + physical health benefits of GLP/GIPs, but so important to broaden the aperture: how is quality of life impacted when on GLP1s for obesity?

Here https://t.co/iwUhgWuylp colleagues and I propose further research needed to better understand QOL 👇

[Daniel J Drucker @DanielJDrucker]

After a strong start, competition for @novonordisk @EliLillyandCo is coming in the #weightloss space, with widespread innovation to bring options for more people @amgen @Roche @AltimmuneInc @StructureTx @Viking_VKTX @pfizer @Boehringer https://t.co/XAD2qoRPvX @TheEconomist

[Tejaswi Kompala @tkompala]

this is what scares me about the obesity and diabetes epidemics --- YOUNG people are impacted, which unfortunately means they grow into adults who will spend more years of their lives with complication, illness. https://t.co/SovMUOmmaD

[Tejaswi Kompala @tkompala]

so important for expanded equitable access to cardiometabolic care https://t.co/CzQHRG3kr2